A Comparative Study of Sibling Oocytes: ICSI vs. the PICSI Sperm Selection Method

NCT ID: NCT03240302

Last Updated: 2017-08-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-09-30

Study Completion Date

2020-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this research is to compare sibling oocytes using two sperm selection methods for choosing the best quality spermatozoa before they are injected into oocytes and the influence of each of these methods on embryo quality and IVF outcome.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ICSI Procedure

The ICSI procedure is the standard procedure of selection and injection of sperm into the oocyte using a standard ICSI petri dish.

Group Type ACTIVE_COMPARATOR

ICSI petri dish

Intervention Type DEVICE

Half of the oocytes will be placed into the standard ICSI petri dish and they will be injected with sperm with normal morphology.

PICSI Procedure

The PICSI procedure is based on a selection of mature spermatozoa with CD44 receptors and their injection into the oocyte using the PICSI petri dish that has been coated with hyaluronic acid on its bottom.

Group Type ACTIVE_COMPARATOR

PICSI petri dish

Intervention Type DEVICE

Half of the oocytes will be placed into a PICSI petri dish (whose bottom is coated with hyaluronic acid) and the mature spermatozoa with CD44 receptors that are attached to the bottom of the dish will be injected into them.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ICSI petri dish

Half of the oocytes will be placed into the standard ICSI petri dish and they will be injected with sperm with normal morphology.

Intervention Type DEVICE

PICSI petri dish

Half of the oocytes will be placed into a PICSI petri dish (whose bottom is coated with hyaluronic acid) and the mature spermatozoa with CD44 receptors that are attached to the bottom of the dish will be injected into them.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Males aged 18-60
* Females aged 18-35
* Males with mild OTA (oligo terato astheno zoospermia) and at least one failed IVF cycle
* Males with normozoospermia with at least 2 unexplained failed IVF cycles
* Females with normal FSH and normal AMH values
* Females who have retrieved in previous cycles at least 6 oocytes

Exclusion Criteria

* Couples who have been exposed to heavy smoking, drugs and chronic diseases
* Males who have undergone testicular surgery (TESE) or defined as severe OTA
* Females with egg factor infertility
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hillel Yaffe Medical Center

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Einat Shalom Paz, MD

Role: PRINCIPAL_INVESTIGATOR

Hillel Yaffe Medical Center

Medeia Michaeli, PhD

Role: STUDY_DIRECTOR

Hillel Yaffe Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hillel Yaffe Medical Center

Hadera, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Medeia Michaeli, PhD

Role: CONTACT

972-50-6246885

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Medeia Michaeli, PhD

Role: primary

972-50-6246885

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HYMC-0069-17

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Automated Sperm Selection
NCT05240469 RECRUITING NA